15-Hydroxyretin-4-one, with the CAS number 62702-55-0, is a derivative of retinoids, which are compounds related to vitamin A and play crucial roles in biological processes, particularly in vision and cellular growth. This compound features a hydroxyl group at the 15th carbon position and a ketone group at the 4th position of the retinoid backbone, which influences its chemical reactivity and biological activity. It is typically characterized by its ability to interact with retinoid receptors, potentially modulating gene expression and influencing cellular differentiation and proliferation. The presence of the hydroxyl and ketone functional groups contributes to its solubility and stability in biological systems. As a retinoid analog, 15-Hydroxyretin-4-one may exhibit antioxidant properties and could be investigated for therapeutic applications in dermatology and oncology. However, its specific pharmacological effects and mechanisms of action require further research to fully understand its potential benefits and risks in clinical settings.

15-Hydroxyretin-4-one

62702-55-0: 15-Hydroxyretin-4-one, 2-Cyclohexen-1-one, 3-(9-hydroxy-3,7-dimethyl-1,3,5,7-nonatetraenyl)-2,4,4-trimethyl-, Retin-4-one, 15-hydroxy-, Retinol, 4-Oxo-, all-trans-4-Oxoretinol, 4-Oxoretinol

4-Keto retinol is an analog of vitamin A, which is used in the treatment of various diseases. It has been shown to reduce the levels of PGE2 and increase the redox potential in cells. 4-Keto retinol has also been shown to increase locomotor activity and improve energy metabolism. The structural analysis of 4-keto retinol has revealed that it binds to DNA polymerase, inhibiting transcriptional activity. The pharmacokinetic properties of this drug have been studied in rats and mice, but not yet humans. This compound will most likely be administered orally or intravenously with a dosage range from 0.01 mg/kg to 10 mg/kg per day.

CAS 62702-55-0: 15-Hydroxyretin-4-one

4-Keto retinol

Ref: 3D-FK24785

4-Keto Retinol (~90%)

Ref: TR-K205000